Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Misonix ups European scope with North Med partnership

This article was originally published in Clinica

Executive Summary

Minimally-invasive ultrasonic technology developer Misonix is set to extend access to its technology in the EU, after teaming up with European distributor North Med. The firms have come together in a two-year exclusive distribution deal that will see Prague-based North Med make Misonix’s SonaStar ultrasonic surgical aspirator, BoneScapel ultrasonic bone cutter and SonicOne ultrasonic wound debrider available in the Czech and Slovak republics. According to Misonix (Farmingdale, New York), its product portfolio is aimed at a combined market valued at around $3bn. The exact financial terms of the deal, which includes minimum purchase requirements, were not revealed. Previously this year, Misonix expanded its European reach by signing a deal with Russian distributor Intermedica, to make its Sonablate 500 high intensity focused ultrasound (HIFU) system available in Russia and surrounding countries (see Clinica No 1316, p 14).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042475

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel